352 related articles for article (PubMed ID: 30002412)
1. RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
Kim CE; Kleinman HK; Sosne G; Ousler GW; Kim K; Kang S; Yang J
Sci Rep; 2018 Jul; 8(1):10500. PubMed ID: 30002412
[TBL] [Abstract][Full Text] [Related]
2. Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model.
Kim CE; Kim YJ; Hwang MW; Park YJ; Yang J
Biomed Pharmacother; 2021 Jul; 139():111571. PubMed ID: 33857915
[TBL] [Abstract][Full Text] [Related]
3. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye.
Li L; Jin R; Li Y; Yoon HS; Yoon HJ; Yoon KC
Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685
[TBL] [Abstract][Full Text] [Related]
4. Effects of silk fibroin in murine dry eye.
Kim CE; Lee JH; Yeon YK; Park CH; Yang J
Sci Rep; 2017 Mar; 7():44364. PubMed ID: 28281688
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model.
Moon I; Kang HG; Yeo A; Noh H; Kim HC; Song JS; Ji YW; Lee HK
J Ocul Pharmacol Ther; 2018 Nov; 34(9):612-620. PubMed ID: 30325678
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study.
Yamane M; Ogawa Y; Fukui M; Kamoi M; Uchino M; Saijo-Ban Y; Kozuki N; Mukai S; Mori T; Okamoto S; Tsubota K
Eye Contact Lens; 2018 Nov; 44 Suppl 2():S215-S220. PubMed ID: 29280750
[TBL] [Abstract][Full Text] [Related]
7. Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium.
Ji YW; Kim HM; Ryu SY; Oh JW; Yeo A; Choi CY; Kim MJ; Song JS; Kim HS; Seo KY; Kim KP; Lee HK
Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):5035-5044. PubMed ID: 31800960
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effect of hydroxyproline-GQDGLAGPK in desiccation stress-induced experimental dry eye mouse.
Lee H; Kim CE; Ahn BN; Yang J
Sci Rep; 2017 Aug; 7(1):7413. PubMed ID: 28785037
[TBL] [Abstract][Full Text] [Related]
9. A New Ophthalmic Pharmaceutical Formulation, Topical Sulglycotide, Enhances the Ocular Mucin Secretion in Desiccation Stress-Mediated Dry Eye Disease.
Lee H; Jeon S; Kim CE; Park YJ; Yang J
Invest Ophthalmol Vis Sci; 2019 Mar; 60(4):1076-1087. PubMed ID: 30901389
[TBL] [Abstract][Full Text] [Related]
10. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
11. Randomized Controlled Study to Investigate the Effect of Topical Diquafosol Tetrasodium on Corneal Sensitivity in Short Tear Break-Up Time Dry Eye.
Kaido M; Kawashima M; Shigeno Y; Yamada Y; Tsubota K
Adv Ther; 2018 May; 35(5):697-706. PubMed ID: 29671255
[TBL] [Abstract][Full Text] [Related]
12. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
[TBL] [Abstract][Full Text] [Related]
13. Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury.
Tabuchi N; Toshida H; Koike D; Odaka A; Suto C; Ohta T; Murakami A
J Ocul Pharmacol Ther; 2017; 33(1):24-33. PubMed ID: 28009531
[TBL] [Abstract][Full Text] [Related]
14. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis.
Mori Y; Nejima R; Masuda A; Maruyama Y; Minami K; Miyata K; Amano S
Cornea; 2014 Jul; 33(7):659-62. PubMed ID: 24858017
[TBL] [Abstract][Full Text] [Related]
15. Ocular surface response of two preservative-free cylcosporine A emulsion eye drops in a mouse model of dry eye.
Daull P; Nagano T; Gros E; Feraille L; Barabino S; Garrigue JS
Curr Eye Res; 2021 Aug; 46(8):1096-1104. PubMed ID: 33588656
[TBL] [Abstract][Full Text] [Related]
16. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Trabodenoson in a Mouse Keratoconjunctivitis Sicca (KCS) Model for Dry-Eye Syndrome.
Žiniauskaite A; Ragauskas S; Hakkarainen JJ; Rich CC; Baumgartner R; Kalesnykas G; Albers DS; Kaja S
Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3088-3093. PubMed ID: 30025146
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model.
Bang SP; Yeon CY; Adhikari N; Neupane S; Kim H; Lee DC; Son MJ; Lee HG; Kim JY; Jun JH
PLoS One; 2019; 14(11):e0224805. PubMed ID: 31738791
[TBL] [Abstract][Full Text] [Related]
19. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
Strong B; Farley W; Stern ME; Pflugfelder SC
Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
[TBL] [Abstract][Full Text] [Related]
20. Effects of Quercetin in a Mouse Model of Experimental Dry Eye.
Oh HN; Kim CE; Lee JH; Yang JW
Cornea; 2015 Sep; 34(9):1130-6. PubMed ID: 26203745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
